Karen H. Lu

Genetic diagnosis and clinical outcome in patients with synchronous ovarian and endometrial cancer

Zhiyuan Luo, Alexander Gammerman, Ian Jacobs, 2008 .

Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges.

Marko Vuskovic, Nicolai V. Bovin, Margaret E. Huflejt, 2009, Molecular immunology.

A Multiplexable, Microfluidic Platform for the Rapid Quantitation of a Biomarker Panel for Early Ovarian Cancer Detection at the Point-of-Care

Robert C. Bast, John T. McDevitt, Jorge Wong, 2014, Cancer Prevention Research.

The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated With Differentiation and Survival in Ovarian Cancer

Michael J. Birrer, Anais Malpica, Karen H. Lu, 2011, The American journal of surgical pathology.

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Sudhir Srivastava, David F. Ransohoff, Martin W. McIntosh, 2011, Cancer Prevention Research.

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations: Missed Opportunities

Karen H. Lu, David M. Gershenson, Larissa A. Meyer, 2010, Obstetrics and gynecology.

Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes

Jie Li, Margaret R. Spitz, Gordon B. Mills, 2012, Journal of Cancer Research and Clinical Oncology.

Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

Robert C. Bast, Keith A. Baggerly, Gordon B. Mills, 2004, Clinical Cancer Research.